Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/25748
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Doré, Vincent | - |
dc.contributor.author | Krishnadas, Natasha | - |
dc.contributor.author | Bourgeat, Pierrick | - |
dc.contributor.author | Huang, Kun | - |
dc.contributor.author | Li, Shenpeng | - |
dc.contributor.author | Burnham, Samantha | - |
dc.contributor.author | Masters, Colin L | - |
dc.contributor.author | Fripp, Jurgen | - |
dc.contributor.author | Villemagne, Victor L | - |
dc.contributor.author | Rowe, Christopher C | - |
dc.date | 2021-01-26 | - |
dc.date.accessioned | 2021-02-01T04:24:36Z | - |
dc.date.available | 2021-02-01T04:24:36Z | - |
dc.date.issued | 2021-07 | - |
dc.identifier.citation | European Journal of Nuclear Medicine and Molecular Imaging 2021; 48(7): 2225-2232 | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/25748 | - |
dc.description.abstract | Previous studies have shown that Aβ-amyloid (Aβ) likely promotes tau to spread beyond the medial temporal lobe. However, the Aβ levels necessary for tau to spread in the neocortex is still unclear. Four hundred sixty-six participants underwent tau imaging with [18F]MK6420 and Aβ imaging with [18F]NAV4694. Aβ scans were quantified on the Centiloid (CL) scale with a cut-off of 25 CL for abnormal levels of Aβ (A+). Tau scans were quantified in three regions of interest (ROI) (mesial temporal (Me); temporoparietal neocortex (Te); and rest of neocortex (R)) and four mesial temporal region (entorhinal cortex, amygdala, hippocampus, and parahippocampus). Regional tau thresholds were established as the 95%ile of the cognitively unimpaired A- subjects. The prevalence of abnormal tau levels (T+) along the Centiloid continuum was determined. The plots of prevalence of T+ show earlier and greater increase along the Centiloid continuum in the medial temporal area compared to neocortex. Prevalence of T+ was low but associated with Aβ level between 10 and 40 CL reaching 23% in Me, 15% in Te, and 11% in R. Between 40 and 70 CL, the prevalence of T+ subjects per CL increased fourfold faster and at 70 CL was 64% in Me, 51% in Te, and 37% in R. In cognitively unimpaired, there were no T+ in R below 50 CL. The highest prevalence of T+ were found in the entorhinal cortex, reaching 40% at 40 CL and 80% at 60 CL. Outside the entorhinal cortex, abnormal levels of cortical tau on PET are rarely found with Aβ below 40 CL. Above 40 CL prevalence of T+ accelerates in all areas. Moderate Aβ levels are required before abnormal neocortical tau becomes detectable. | en |
dc.language.iso | eng | - |
dc.subject | Alzheimer’s disease | en |
dc.subject | Aβ-amyloid imaging | en |
dc.subject | Neurodegeneration | en |
dc.subject | Positron emission tomography | en |
dc.subject | Tau imaging | en |
dc.subject | Tauopathies | en |
dc.title | Relationship between amyloid and tau levels and its impact on tau spreading. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | European Journal of Nuclear Medicine and Molecular Imaging | en |
dc.identifier.affiliation | The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | The Australian Dementia Network (ADNeT), Melbourne, Australia | en |
dc.identifier.affiliation | Health and Biosecurity Flagship, The Australian eHealth Research Centre, Brisbane, Queensland, Australia | en |
dc.identifier.affiliation | Health and Biosecurity Flagship, The Australian eHealth Research Centre, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Molecular Imaging and Therapy | en |
dc.identifier.doi | 10.1007/s00259-021-05191-9 | en |
dc.type.content | Text | en |
dc.identifier.orcid | 0000-0002-8051-0558 | en |
dc.identifier.pubmedid | 33495928 | - |
local.name.researcher | Doré, Vincent | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | The Florey Institute of Neuroscience and Mental Health | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.